
TSE:CGY
This summary was created by AI, based on 1 opinions in the last 12 months.
Calian Group Ltd (CGY-T) has received positive reviews from experts, highlighting its strong performance in the recent quarter. The company has not only reached a 52-week high but also shows signs of sustained momentum in its stock price. This solid performance reflects the company's well-run operations and strategic direction. With the backing of analysts, the recommendation is to continue holding onto the stock, indicating confidence in its ongoing potential for growth. Overall, Calian Group Ltd appears to be in a strong position within its market, making it an attractive option for investors looking for stability and solid returns.
He used to own it a long time ago. It stalled out and he sold. It is finally getting traction again. They are trying to diversify the business. If they lose a big contract it could really impact the results. The dividend is safe. He would like to buy it much more cheaply but he would not buy at these levels.
It does 145 pharmacies by Loblaw’s (L-T) and medical services for the Canadian Defence Department, as well as a satellite business out of Saskatoon. One of the most consistently profitable small-cap companies for the last 5 years. 4% dividend yield. (Analysts’ price target is $31.00.)